Marine Protein Hydrolysate as Dietary Supplement in Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Interventions:   Dietary Supplement: MPH_active;   Dietary Supplement: MPH_placebo Sponsors:   Helse Møre og Romsdal HF;   Haukeland University Hospital;   University of Bergen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2019 Category: Research Source Type: clinical trials

Hydrogen Breath Test an Instrument to Predict Rifaximin-Response in Irritable Bowel Syndrome Predominant Diarrhea
Conditions:   Irritable Bowel Syndrome;   Irritable Bowel Syndrome With Diarrhea Interventions:   Drug: Rifaximin;   Device: Glucose and lactulose hydrogen breath testing Sponsors:   University of Michigan;   Commonwealth Diagnostics International, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2018 Category: Research Source Type: clinical trials

A Trial for New Treatment of Adult Patients With Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Interventions:   Biological: MRx1234 [Blautia Hydrogenotrophica];   Other: Placebo Sponsor:   4DPharma PLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2018 Category: Research Source Type: clinical trials

Effect of electroacupuncture at homotopic and heterotopic acupoints on abdominal pain in patients with irritable bowel syndrome: study protocol for a randomized controlled trial
This study is a randomized, single-blinded, controlled, four-arm parallel trial. A total of 144  patients will be randomly assigned to four groups: a homotopic noxious stimulation group (group A), a homotopic innocuous stimulation group (group B), a heterotopic noxious stimulation group (group C), and a heterotopic innocuous stimulation group (group D). Each patient will receive 14 sessions o f treatment, twice per week for 7 weeks. The primary outcome will be pain intensity measured with the visual analog scale. The secondary outcomes will include the IBS Symptom Severity Scale, IBS Quality of Life question...
Source: Trials - October 16, 2018 Category: Research Source Type: clinical trials

Acupuncture for irritable bowel syndrome: study protocol for a multicenter randomized controlled trial
DiscussionThis is a multicenter randomized controlled trial for IBS in China. It may clarify the efficacy of acupuncture as an alternative therapy for IBS. This is the first time ever that the potential mechanism of IBS based on genomics has been investigated.Trial registrationChinese Clinical Trials Register, ID:ChiCTR-IOR-15006259. First registered on 14 April 2015. (Source: Trials)
Source: Trials - October 1, 2018 Category: Research Source Type: clinical trials